Conestoga Capital Advisors Holds 5.3% Stake in Vericel Corp

TL;DR

**Conestoga Capital still owns 5.3% of Vericel, signaling institutional confidence.**

AI Summary

Conestoga Capital Advisors, LLC, an investment adviser based in Wayne, PA, has updated its ownership stake in Vericel Corp, a biological products company, as of December 31, 2023. The filing, an SC 13G/A, shows Conestoga now beneficially owns 2,339,960 shares of Vericel's Common Stock, representing 5.3% of the company. This matters to investors because it indicates a significant institutional investor maintains a substantial position, suggesting continued confidence in Vericel's long-term prospects.

Why It Matters

This filing shows a major institutional investor, Conestoga Capital Advisors, continues to hold a significant stake in Vericel, which can be seen as a vote of confidence in the company's future performance.

Risk Assessment

Risk Level: low — This filing indicates a stable, significant institutional ownership, which generally reduces volatility and provides a level of confidence.

Analyst Insight

Investors should note that a significant institutional investor, Conestoga Capital Advisors, maintains a substantial 5.3% stake in Vericel Corp, which could be interpreted as a positive signal for the company's stability and long-term prospects. This information might encourage further due diligence into Vericel's fundamentals.

Key Numbers

• 2,339,960 — Shares Owned (Represents the total number of Vericel Corp shares Conestoga Capital Advisors, LLC beneficially owns.)
• 5.3% — Ownership Percentage (Indicates the proportion of Vericel Corp's common stock held by Conestoga Capital Advisors, LLC, showing a significant stake.)

Key Players & Entities

• Conestoga Capital Advisors, LLC (company) — the reporting person and investment adviser
• Vericel Corp (company) — the subject company, a biological products manufacturer
• 2,339,960 (dollar_amount) — shares beneficially owned by Conestoga Capital Advisors
• 5.3% (dollar_amount) — percentage of Vericel Corp's common stock owned by Conestoga Capital Advisors
• December 31, 2023 (date) — the date of the event requiring this filing

Forward-Looking Statements

• Conestoga Capital Advisors will maintain a significant stake in Vericel Corp. (Conestoga Capital Advisors, LLC) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• vcela1_10524.htm (SC 13G/A) — 25KB
• 0001085146-24-000040.txt ( ) — 27KB

(a)

ITEM 1(a). NAME OF ISSUER: Vericel Corporation

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 64 Sidney Street Cambridge, MA 02139

(a)

ITEM 2(a). NAME OF PERSON FILING: Conestoga Capital Advisors LLC

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 550 E. Swedesford Rd. Ste 120 Wayne, PA 19087

(c)

ITEM 2(c). CITIZENSHIP: Delaware

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock

(e)

ITEM 2(e). CUSIP NUMBER: 92346J108 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 2,495,619 (b) Percent of class: 5.23% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Conestoga Capital Advisors LLC : 2,339,960 (ii) shared power to vote or to direct the vote: Conestoga Capital Advisors LLC : 0 (iii) sole power to dispose or direct the disposition of: Conestoga Capital Advisors LLC : 2,495,619 (iv) shared power to dispose or to direct the disposition of: Conestoga Capital Advisors LLC : 0 ITEM 5. If this statement is being filed to report the fact that

View Full Filing

View this SC 13G/A filing on SEC EDGAR